Menu
Search
|

Menu

Close
X

China Resources Double-Crane Pharmaceutical Co Ltd 600062.SS (Shanghai Stock Exchange)

16.05 CNY
+0.09 (+0.56%)
As of 2:00 AM EST
chart
Previous Close 15.96
Open 15.85
Volume 3,832,518
3m Avg Volume 4,705,346
Today’s High 16.19
Today’s Low 15.68
52 Week High 22.73
52 Week Low 13.30
Shares Outstanding (mil) 1,043.24
Market Capitalization (mil) 16,587.48
Forward P/E 17.25
Dividend (Yield %) 0.08 ( 0.51 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.50 Mean rating from 10 analysts

KEY STATS

Revenue (mm, CNY)
FY18
6,310
FY17
6,422
FY16
5,495
FY15
5,847
EPS (CNY)
FY18
0.809
FY17
0.808
FY16
0.685
FY15
0.757
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
17.25
29.53
Price to Sales (TTM)
vs sector
2.08
22.95
Price to Book (MRQ)
vs sector
2.15
4.15
Price to Cash Flow (TTM)
vs sector
--
20.94
Total Debt to Equity (MRQ)
vs sector
1.27
15.47
LT Debt to Equity (MRQ)
vs sector
1.01
11.13
Return on Investment (TTM)
vs sector
12.71
13.00
Return on Equity (TTM)
vs sector
12.78
14.69

EXECUTIVE LEADERSHIP

Chuncheng Wang
Chairman of the Board, Since 2015
Salary: --
Bonus: --
Xin Li
President, Director, Since 2005
Salary: --
Bonus: --
Yanxi Fan
Vice President, Secretary of the Board, Director, Since 2012
Salary: --
Bonus: --
Zhiyong Ge
Vice President, Since 2005
Salary: --
Bonus: --
Jun Ni
Vice President, Since 2012
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

No.1 Li Ze East Second Road
Wangjing Area, Chaoyang District
BEIJING   BEJ   100102

Phone: +8610.64398099
Site: www.dcpc.com

CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the development, manufacture and distribution of pharmaceuticals. The Company's main businesses are classified into three segments: Chronic Disease segment, Specialist segment and Infusion segment. Chronic Disease segment mainly provides products for lowering blood pressure, blood fat and blood glucose. Specialist segment mainly involves in the research, development and distribution of pharmaceuticals targeting six areas, including cardiovascular and cerebrovascular, pediatrics, kidney disease, mental/nerve, anesthesia and analgesia and respiratory areas. Infusion segment various types of infusion products, such as basic infusion, therapeutic infusion and nutritional. The Company distributes its products mainly in domestic market.

SPONSORED STORIES